Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma
Authors:
Open Access
- 17 February 2023
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 30, S81-S91
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (2021MD703827)
- National Key Research and Development Program of China (2019YFC0118100)
- National Natural Science Foundation of China (62171167, 81873910)
This publication has 34 references indexed in Scilit:
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International, 2017
- Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical ConsiderationsRadioGraphics, 2017
- The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaJournal of Hepatology, 2017
- Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative studyOncotarget, 2016
- Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialJournal of Hepatology, 2016
- Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)Digestive Diseases, 2015
- Transarterial chemoembolization: Modalities, indication, and patient selectionJournal of Hepatology, 2015
- Survival analysis of proposed BCLC‐B subgroups in hepatocellular carcinoma patientsLiver International, 2014
- Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B)Japanese Journal of Radiology, 2014
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancerAnnals of Oncology, 2013